Open Access

RE-DUAL PCI and reversal: improving care decisions after coronary revascularisation

Event: ESC CONGRESS 2017
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium
Sponsored by Boehringer Ingelheim
Date: 28 August 2017
Time: 12:45 - 13:45

Congress Session

4 presentations in this session

Antithrombotic strategies post-PCI: what do we know so far?

Speaker: Professor G. Nickenig (Bonn, DE)
Thumbnail

Dual vs triple antithrombotic therapy: new evidence.

Speaker: Professor C. Cannon (Boston, US)
Thumbnail

Safety, efficacy, control: choosing the right oral anticoagulant for our patients.

Speaker: Professor T. Villines (Charlottesville, US)
Thumbnail

Panel discussion Q&A - RE-DUAL PCI and reversal: improving care decisions after coronary revascularisation.

Speaker: Professor C. Cannon (Boston, US)
Thumbnail

4 speakers from this session

Professor Georg Nickenig

Heartcenter Bonn, University Hospital Bonn, Bonn (Germany)
15 presentations
0 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Professor Todd Villines

University of Virginia, Charlottesville (United States of America)
7 presentations
0 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

This platform is supported by

logo Novo Nordisk